GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7MJK | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2) | |
7N0H | P0DTC2 | CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45) | |
7N1Q | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1T | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1U | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1V | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1W | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1X | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N1Y | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
7N3I | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 | |
7N62 | P0DTC2 | SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) | |
7N64 | P0DTC2 | SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) | |
7N8H | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
7N8I | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
7ND3 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab | |
7ND4 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab | |
7ND5 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab | |
7ND6 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab | |
7ND7 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab | |
7ND8 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab | |
7ND9 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab | |
7NDA | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab | |
7NDB | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab | |
7NDC | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159 | |
7NDD | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159 | |
7NEH | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab | |
7NKT | P0DTC2 | RBD domain of SARS-CoV2 in complex with neutralizing nanobody NM1226 | |
7NT9 | P0DTC2 | Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation) | |
7NTA | P0DTC2 | Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect) | |
7NTC | P0DTC2 | Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab | |
7NX6 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NX7 | P0DTC2 | Crystal structure of the K417N mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NX8 | P0DTC2 | Crystal structure of the K417T mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NX9 | P0DTC2 | Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NXA | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 B.1.351 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NXB | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NXC | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2 | |
7OAN | P0DTC2 | Nanobody C5 bound to Spike | |
7OAO | P0DTC2 | Nanobody C5 bound to RBD | |
7OAP | P0DTC2 | Nanobody H3 AND C1 bound to RBD | |
7OAQ | P0DTC2 | Nanobody H3 AND C1 bound to RBD with Kent mutation | |
7OAU | P0DTC2 | Nanobody C5 bound to Kent variant RBD (N501Y) | |
7OAY | P0DTC2 | Nanobody F2 bound to RBD | |
7OR9 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and COVOX-278 Fabs | |
7ORA | P0DTC2 | Crystal structure of the T478K mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-45 and COVOX-253 Fabs | |
7ORB | P0DTC2 | Crystal structure of the L452R mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-75 and COVOX-253 Fabs | |
7P77 | P0DTC2 | SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation | |
7P78 | P0DTC2 | SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation | |
7P79 | P0DTC2 | SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation. | |
7P7A | P0DTC2 | SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024